Overview
Kei Kushitani practices practicing medicine in Hiroshima, Japan.
Kushitani is highly rated in 4 conditions, according to our data. Their clinical expertise encompasses Mesothelioma, Squamous Cell Lung Carcinoma, Lung Adenocarcinoma, and Lung Cancer.
They are actively involved in clinical research, co-authoring 60 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Kei Kushitani
Is Kei Kushitani a top-rated expert for Mesothelioma?
MediFind is an objective health platform that identifies experts based on real-world data. Kei Kushitani is classified as an Distinguished expert for Mesothelioma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Kei Kushitani participate in research or clinical trials?
Yes. Kei Kushitani has published 60 articles and abstracts on conditions like Mesothelioma. You can view a list of Kei Kushitani's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- MesotheliomaKushitani isDistinguished. Learn about Mesothelioma.
- Squamous Cell Lung CarcinomaKushitani isDistinguished. Learn about Squamous Cell Lung Carcinoma.
- Advanced
- Lung AdenocarcinomaKushitani isAdvanced. Learn about Lung Adenocarcinoma.
- Lung CancerKushitani isAdvanced. Learn about Lung Cancer.
- Experienced
- EGFR Positive Lung CancerKushitani isExperienced. Learn about EGFR Positive Lung Cancer.
- Inflammatory Myofibroblastic TumorKushitani isExperienced. Learn about Inflammatory Myofibroblastic Tumor.
- Large-Cell Lung CarcinomaKushitani isExperienced. Learn about Large-Cell Lung Carcinoma.
- Neuroendocrine TumorKushitani isExperienced. Learn about Neuroendocrine Tumor.
- Non-Small Cell Lung Cancer (NSCLC)Kushitani isExperienced. Learn about Non-Small Cell Lung Cancer (NSCLC).
- Secondary PeritonitisKushitani isExperienced. Learn about Secondary Peritonitis.
- Small Cell Lung Cancer (SCLC)Kushitani isExperienced. Learn about Small Cell Lung Cancer (SCLC).
- Squamous Cell Carcinoma of the Anal Canal (SCAC)